EGALET LTD has a total of 69 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and medical technology are EGALET AS, OHR PHARMA LLC and KERKHOF NICHOLAS J.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 18 | |
#2 | Australia | 11 | |
#3 | EPO (European Patent Office) | 11 | |
#4 | New Zealand | 8 | |
#5 | Canada | 5 | |
#6 | South Africa | 4 | |
#7 | Israel | 3 | |
#8 | China | 2 | |
#9 | Hong Kong | 2 | |
#10 | WIPO (World Intellectual Property Organization) | 2 | |
#11 | Brazil | 1 | |
#12 | Republic of Korea | 1 | |
#13 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Medical purpose containers | |
#4 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Olsen Martin Rex | 30 |
#2 | Tygesen Peter Holm | 28 |
#3 | Lindhardt Karsten | 28 |
#4 | Bar-Shalom Daniel | 21 |
#5 | Haahr Anne-Mette | 19 |
#6 | Andersen Christine | 18 |
#7 | Overgard Jan Martin | 16 |
#8 | Lyhne-Iversen Louise Inoka | 16 |
#9 | Skak Nikolaj | 14 |
#10 | Elhauge Torben | 14 |
Publication | Filing date | Title |
---|---|---|
CN111511434A | Oral delivery of active drug substances | |
AU2015200243A1 | Controlled release formulations | |
AU2013285988A1 | Abuse deterrent pharmaceutical compositions for controlled release | |
AU2012258350A1 | Controlled release formulations | |
NZ594208A | Pharmaceutical compositions resistant to abuse | |
EP2393484A1 | Immediate release composition resistant to abuse by intake of alcohol | |
AU2008258596A1 | Controlled release pharmaceutical compositions for prolonged effect | |
AU2006254554A1 | A solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids | |
EP1758557A2 | Swellable dosage form comprising gellan gum | |
EP2957281A1 | Polymer release system |